15.03
price down icon0.07%   -0.010
after-market Handel nachbörslich: 14.99 -0.04 -0.27%
loading

Finanzdaten der Amarin Corp Adr-Aktie (AMRN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
73.12%
72.74
42.02 62.31 42.30 67.49
Cost Of Revenue
32.52%
22.38
16.89 71.87 26.02 24.72
Gross Profit
100.41%
50.36
25.13 -9.567 16.28 42.77
Operating Expenses
58.40%
66.35
41.88 42.95 41.44 43.29
Benefits Costs and Expenses
54.89%
86.19
55.65 112.21 63.83 64.60
Costs And Expenses
54.89%
86.19
55.65 112.21 63.83 64.60
Operating Income/Loss
4.60%
-15.98
-16.75 -52.52 -25.17 -0.524
Income/Loss From Continuing Operations Before Tax
1.32%
-13.45
-13.63 -49.91 -21.53 2.892
Income Tax Expense/Benefit
66.67%
0.689
2.067 -1.289 3.605 1.37
Income/Loss From Continuing Operations After Tax
9.93%
-14.14
-15.70 -48.62 -25.13 1.522
Net Income/Loss
9.93%
-14.14
-15.70 -48.62 -25.13 1.522
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.26%
414.48
413.42 0.151 411.15 410.85
Diluted Average Shares
0.26%
414.48
413.42 0.151 411.15 411.39
Basic Earnings Per Share
25.00%
-0.03
-0.04 -0.12 -0.06 -
Diluted Earnings Per Share
25.00%
-0.03
-0.04 -0.12 -0.06 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general SNY
$45.33
price down icon 9.14%
drug_manufacturers_general PFE
$24.54
price down icon 1.01%
$112.77
price down icon 0.19%
$280.10
price down icon 1.32%
drug_manufacturers_general NVO
$56.14
price down icon 1.06%
drug_manufacturers_general MRK
$84.05
price down icon 0.15%
Kapitalisierung:     |  Volumen (24h):